Does Dr. WAEL ALI SAKR ESA have financial conflicts of interest?

Dr. WAEL ALI SAKR ESA (M.D.) has received a total of $140 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $140 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. WAEL ALI SAKR ESA?

According to CMS Open Payments data, Dr. WAEL ALI SAKR ESA received funding from PAJUNK MEDICAL SYSTEMS ($60), TREVENA ($42), and PACIRA PHARMACEUTICALS INCORPORATED ($38).

Does Dr. WAEL ALI SAKR ESA receive research grants or speaking fees?

Dr. WAEL ALI SAKR ESA has received $140 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. WAEL ALI SAKR ESA

M.D.Real-Time Hydrated

Specialty: Anesthesiology

Practice Location: CLEVELAND, OH 44195

NPI Number: 1194999631

LIFETIME INDUSTRY VALUE

$140

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALI SAKR ESA is a verified Anesthesiology practitioner based in CLEVELAND, OH.

Between 2021 and 2025, Dr. ALI SAKR ESA had an overall industry promotional and research financial footprint of $140 as recorded in the federal CMS Open Payments database.

$140 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALI SAKR ESA's primary funding source is PAJUNK MEDICAL SYSTEMS, which accounts for $60 (representing 42.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PAJUNK MEDICAL SYSTEMS

Rank 1

$60

42.8%

TREVENA

Rank 2

$42

30.2%

PACIRA PHARMACEUTICALS INCORPORATED

Rank 3

$38

27%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.